IndraLab

Statements


USP25 deubiquitinates APP. 1 / 1
1 |

"Similarly to what occurs with?CD3delta, overexpression of?USP25?increases APP half-life. Again, this effect depends on the catalytic activity of?USP25, as catalytically inactive?USP25(C178S) does not alter APP turnover."